237 related articles for article (PubMed ID: 33968044)
1. Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma.
Tang XX; Shimada H; Ikegaki N
Front Immunol; 2021; 12():650427. PubMed ID: 33968044
[TBL] [Abstract][Full Text] [Related]
2. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
3. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
4. The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells.
Hidalgo LG; Einecke G; Allanach K; Halloran PF
Am J Transplant; 2008 Mar; 8(3):627-36. PubMed ID: 18294159
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Natural Killer and CD8
Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
[TBL] [Abstract][Full Text] [Related]
6. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
Campoli M; Ferrone S
Tissue Antigens; 2008 Oct; 72(4):321-34. PubMed ID: 18700879
[TBL] [Abstract][Full Text] [Related]
7. Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors.
Okoye I; Xu L; Motamedi M; Parashar P; Walker JW; Elahi S
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33310773
[TBL] [Abstract][Full Text] [Related]
8. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
9. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
10. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.
Parihar R; Rivas C; Huynh M; Omer B; Lapteva N; Metelitsa LS; Gottschalk SM; Rooney CM
Cancer Immunol Res; 2019 Mar; 7(3):363-375. PubMed ID: 30651290
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis.
Zaguia F; Saikali P; Ludwin S; Newcombe J; Beauseigle D; McCrea E; Duquette P; Prat A; Antel JP; Arbour N
J Immunol; 2013 Mar; 190(6):2510-8. PubMed ID: 23396942
[TBL] [Abstract][Full Text] [Related]
12. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage.
Takeuchi A; Badr Mel S; Miyauchi K; Ishihara C; Onishi R; Guo Z; Sasaki Y; Ike H; Takumi A; Tsuji NM; Murakami Y; Katakai T; Kubo M; Saito T
J Exp Med; 2016 Jan; 213(1):123-38. PubMed ID: 26694968
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
[TBL] [Abstract][Full Text] [Related]
14. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
15. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
16. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
Sarkar AK; Nuchtern JG
Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179
[TBL] [Abstract][Full Text] [Related]
17. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
18. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
19. The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis.
Jensen M; Ernestus K; Kemshead J; Klehr M; Von Bergwelt-Baildon MS; Schinköthe T; Schultze JL; Berthold F
Clin Exp Immunol; 2003 Nov; 134(2):253-63. PubMed ID: 14616785
[TBL] [Abstract][Full Text] [Related]
20. Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.
Jing W; Gershan JA; Johnson BD
Blood; 2009 Apr; 113(18):4449-57. PubMed ID: 19182203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]